Anaemia Monitoring

Monitoring

In people with anaemia of CKD, haemoglobin should be monitored:

• Every 2-4 weeks in the induction phase of erythropoiesis-stimulating agent therapy.
• Every 1-3 months in the maintenance phase of erythropoiesis-stimulating agent therapy.
• More actively after dose adjustment of the erythropoiesis-stimulating agent.

Other factors which contribute to the anaemia of CKD (eg, iron or folate deficiency) should be corrected before treatment and monitored during therapy.

FIND OUT MORE